Company intelligence / Profile preview
Theralase Technologies Inc.
Toronto, Ontario, Canadatheralase.com ↗
- Ownership
- Public · TLT
- Development stage
- Phase 2
01
Overview
Theralase has reported positive Phase II data in BCG-unresponsive NMIBC with a 58% complete response at 90 days and 35% at 450 days using its Ruvidar PDC plus TLC‑3200 laser system. Over 80% of patients remained in the study after 90 days. The company has submitted pre-Breakthrough Designation updates to the FDA. For CLT devices targeting knee pain and other indications, products are Health Canada/FDA approved with ongoing expansion into new indications such as Parkinson’s disease motor/non-motor symptom improvement
- Therapeutic areas
- OncologyRheumatologyNeurology
- Modalities
- Photo Dynamic Compounds (PDCs)medical laser systems
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
In-license of PDC technology from Virginia Polytechnic Institute & State University ("Virginia Tech")academic collaborations with University of Windsor on clinical studies
Beyond the preview
Go deeper on Theralase Technologies Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Theralase Technologies Inc..